Pascal Touchon
Operating Partner at Jeito Capital
About
Operating Partner with over 35 years in the sector; former CEO of Atara Biotherapeutics and Global Head of Cell & Gene at Novartis Oncology. He represents Jeito on the boards of CatalYm and XyloCor Therapeutics.
Colleagues at Jeito Capital
Alain Rougon
Chief Financial Officer (external provider, Prodensia) at Jeito Capital
Anastasiya Sybirna
Principal at Jeito Capital
Annette Clancy
Pharma M&A Strategy at Jeito Capital
Benjamin Caillier
Finance Director, Jeito Capital at Jeito Capital
Boris Kere
Compliance Officer at Jeito Capital
Charlotte Formont
Senior Legal Counsel at Jeito Capital
Chloé Morlaàs
Investor Relations Director at Jeito Capital
Chloé Roche
Analyst at Jeito Capital